Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
CDC42EP3 antisense RNA 1 (CDC42EP3-AS1)
- Target
- CDC42EP3-AS1
- Molecular classification
- Long non-coding RNA, Antisense RNA
01
Overview
CDC42EP3 antisense RNA 1 (CDC42EP3-AS1) is a long non-coding RNA (lncRNA) transcribed from the complementary DNA strand opposite to the CDC42EP3 gene. As an antisense lncRNA, it is classified as a regulatory RNA molecule that does not encode a protein, and may influence the expression or splicing of its sense gene partner or other genes via cis- or trans-acting mechanisms[1][3][4]. Antisense lncRNAs are known to play broad roles in the regulation of gene expression, epigenetic modulation, and chromatin structure, and have been implicated in fundamental cellular processes and sometimes in human diseases, particularly as gene regulators in cancer and other conditions[1][3]. However, as of this search, there is no evidence of CDC42EP3-AS1 serving as a pharmacological drug target or being directly actionable in clinical practice[4][9][11].
- Other names
- LINC03063AC006369.1
02
Biological functions
Regulation of gene expressionEpigenetic regulationCis- and trans-acting RNA-mediated modulation
03
Disease associations
Other (potential cancer association as a regulatory RNA, but no direct evidence for CDC42EP3-AS1 specifically)
Beyond the preview
Go deeper on CDC42EP3 antisense RNA 1 (CDC42EP3-AS1).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on CDC42EP3 antisense RNA 1 (CDC42EP3-AS1).